Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Learn how minimally invasive gynecologic surgery (MIGS) can help reduce pain, reduce recovery time and make gynecologic ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

The completion of a new drug application for the combination of avutometinib and defactinib in KRAS-mutant ovarian cancer is expected to be finalized with the FDA by the end of the month.

Any woman can be at risk for any gynecologic cancer. Risk tends to increase with age, and there is always a heightened possibility of cancer due to family history or race. The baby boy, born in late ...

Three of the leading chatbots can provide basic information about endometriosis, a painful gynecologic condition that affects ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Objective: Myocardial edema is an early manifestation of chemotherapy-related myocardial injury. In this study, we used cardiac magnetic resonance (CMR) T2 mapping to assess myocardial edema and its ...

In a deal with prosecutors, Mark Albert Rettenmaier admitted to downloading more than 200 images on several electronic ...

Uterine cancer (also known as endometrial cancer) is the fourth most common cancer women in the U.S. are diagnosed with. It ...